http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110461837-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110461837-B |
| titleOfInvention | Novel pyrrolopyridine derivatives, their preparation method and use |
| abstract | The present invention relates to novel pyrrolopyridine derivatives represented by chemical formula I, their racemates, stereoisomers, their pharmaceutically acceptable salts and methods for preparing them. The compounds represented by the following chemical formula I are immune to human immunodeficiency The virus (HIV) has high selectivity and physiological activity and low toxicity, and thus can be effective as a therapeutic agent against viral infections, especially human immunodeficiency virus (HIV) infections. |
| priorityDate | 2017-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.